These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 30891618)

  • 1. Clinical significance of circulatory microRNA-203 in serum as novel potential diagnostic marker for multiple myeloma.
    Gupta N; Kumar R; Seth T; Garg B; Sati HC; Sharma A
    J Cancer Res Clin Oncol; 2019 Jun; 145(6):1601-1611. PubMed ID: 30891618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting of stromal versican by miR-144/199 inhibits multiple myeloma by downregulating FAK/STAT3 signalling.
    Gupta N; Kumar R; Seth T; Garg B; Sharma A
    RNA Biol; 2020 Jan; 17(1):98-111. PubMed ID: 31532704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Versican and its associated molecules: potential diagnostic markers for multiple myeloma.
    Gupta N; Khan R; Kumar R; Kumar L; Sharma A
    Clin Chim Acta; 2015 Mar; 442():119-24. PubMed ID: 25623955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of miR-144/199 promote myeloma pathogenesis via upregulation of versican and FAK/STAT3 signaling.
    Gupta N; Kumar R; Sharma A
    Mol Cell Biochem; 2021 Jun; 476(6):2551-2559. PubMed ID: 33649985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Circulating Serum MicroRNA as Diagnostic Biomarkers for Multiple Myeloma].
    Xu YN; Xiao CR; Huang YD; Lu QY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):471-475. PubMed ID: 28446295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a novel microRNA, miR-4449, as a potential blood based marker in multiple myeloma.
    Shen X; Ye Y; Qi J; Shi W; Wu X; Ni H; Cong H; Ju S
    Clin Chem Lab Med; 2017 May; 55(5):748-754. PubMed ID: 27155004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating miRNAs as diagnostic biomarkers for multiple myeloma and monoclonal gammopathy of undetermined significance.
    Li J; Zhang M; Wang C
    J Clin Lab Anal; 2020 Jun; 34(6):e23233. PubMed ID: 32039495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low serum miR-19a expression as a novel poor prognostic indicator in multiple myeloma.
    Hao M; Zang M; Wendlandt E; Xu Y; An G; Gong D; Li F; Qi F; Zhang Y; Yang Y; Zhan F; Qiu L
    Int J Cancer; 2015 Apr; 136(8):1835-44. PubMed ID: 25220540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating Serum MicroRNA-130a as a Novel Putative Marker of Extramedullary Myeloma.
    Besse L; Sedlarikova L; Kryukov F; Nekvindova J; Radova L; Slaby O; Kuglik P; Almasi M; Penka M; Krejci M; Adam Z; Pour L; Sevcikova S; Hajek R
    PLoS One; 2015; 10(9):e0137294. PubMed ID: 26389804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating serum microRNAs as novel diagnostic and prognostic biomarkers for multiple myeloma and monoclonal gammopathy of undetermined significance.
    Kubiczkova L; Kryukov F; Slaby O; Dementyeva E; Jarkovsky J; Nekvindova J; Radova L; Greslikova H; Kuglik P; Vetesnikova E; Pour L; Adam Z; Sevcikova S; Hajek R
    Haematologica; 2014 Mar; 99(3):511-8. PubMed ID: 24241494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of Serum MicroRNAs in the Auxiliary Diagnosis of Non-Small Cell Lung Cancer.
    Shi GL; Chen Y; Sun Y; Yin YJ; Song CX
    Clin Lab; 2017 Jan; 63(1):133-140. PubMed ID: 28164492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum high expression of miR-214 and miR-135b as novel predictor for myeloma bone disease development and prognosis.
    Hao M; Zang M; Zhao L; Deng S; Xu Y; Qi F; An G; Qin Y; Sui W; Li F; Yang W; Li Z; Yi S; Zou D; Zhan F; Qiu L
    Oncotarget; 2016 Apr; 7(15):19589-600. PubMed ID: 26995755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of circulating microRNAs as diagnostic biomarkers for use in multiple myeloma.
    Jones CI; Zabolotskaya MV; King AJ; Stewart HJ; Horne GA; Chevassut TJ; Newbury SF
    Br J Cancer; 2012 Dec; 107(12):1987-96. PubMed ID: 23169280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating microRNA-133, microRNA-17 and microRNA-25 in serum and its potential diagnostic value in gastric cancer.
    ZiaSarabi P; Sorayayi S; Hesari A; Ghasemi F
    J Cell Biochem; 2019 Aug; 120(8):12376-12381. PubMed ID: 30861177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of circulating miRNAs in multiple myeloma.
    Zhang J; Xiao X; Liu J
    Sci China Life Sci; 2015 Dec; 58(12):1262-9. PubMed ID: 26607481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of serum microRNA-205 as a potential diagnostic and prognostic biomarker for human glioma.
    Yue X; Lan F; Hu M; Pan Q; Wang Q; Wang J
    J Neurosurg; 2016 Jan; 124(1):122-8. PubMed ID: 26230475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum exosomal microRNAs as novel biomarkers for multiple myeloma.
    Zhang ZY; Li YC; Geng CY; Zhou HX; Gao W; Chen WM
    Hematol Oncol; 2019 Oct; 37(4):409-417. PubMed ID: 31102419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma MicroRNA-34a as a Potential Biomarker for Early Diagnosis of Esophageal Cancer.
    Lin Y; Lin Z; Fang Z; Li H; Zhi X; Zhang Z
    Clin Lab; 2019 Nov; 65(11):. PubMed ID: 31710448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential value of circulatory microRNA122 gene expression as a prognostic and metastatic prediction marker for breast cancer.
    Saleh AA; Soliman SE; Habib MSE; Gohar SF; Abo-Zeid GS
    Mol Biol Rep; 2019 Jun; 46(3):2809-2818. PubMed ID: 30835039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating miR-20a and miR-26a as Biomarkers in Prostate Cancer.
    Mohammadi Torbati P; Asadi F; Fard-Esfahani P
    Asian Pac J Cancer Prev; 2019 May; 20(5):1453-1456. PubMed ID: 31127907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.